Altamira Therapeutics Ltd.: xbrl:AccountingProfit

Value{"amount": -3969020, "currency": "USD"}
Period2023-01-01 – 2023-12-31
Statussuperseded
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-24-034940
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/96169b25-4e93-4dbb-a65e-6f07d0f7ae36

History